Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for 60 Degrees Pharmaceuticals (SXTP) over the last 3 years, with Q3 2025 value amounting to $1230.0.

  • 60 Degrees Pharmaceuticals' Exchange Rate Effect fell 3082.11% to $1230.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6575.0, marking a year-over-year decrease of 8839.71%. This contributed to the annual value of $499.0 for FY2024, which is 9919.32% down from last year.
  • As of Q3 2025, 60 Degrees Pharmaceuticals' Exchange Rate Effect stood at $1230.0, which was down 3082.11% from $17242.0 recorded in Q2 2025.
  • Over the past 5 years, 60 Degrees Pharmaceuticals' Exchange Rate Effect peaked at $54175.0 during Q4 2023, and registered a low of -$9904.0 during Q1 2025.
  • Over the past 3 years, 60 Degrees Pharmaceuticals' median Exchange Rate Effect value was $1230.0 (recorded in 2025), while the average stood at $6447.3.
  • Within the past 5 years, the most significant YoY rise in 60 Degrees Pharmaceuticals' Exchange Rate Effect was 102106.63% (2025), while the steepest drop was 110194.17% (2025).
  • Quarter analysis of 3 years shows 60 Degrees Pharmaceuticals' Exchange Rate Effect stood at $54175.0 in 2023, then tumbled by 103.68% to -$1993.0 in 2024, then skyrocketed by 161.72% to $1230.0 in 2025.
  • Its last three reported values are $1230.0 in Q3 2025, $17242.0 for Q2 2025, and -$9904.0 during Q1 2025.